Although DHX37 expression has no significant correlations with tumor purity in both LIHC (r = 0.032, P = 5.57e − 01) and LUAD (r = 0.021, P = 5.44e − 01), these findings strongly suggest that DHX37 may participate in immune response to affect patient survival in cancers like LIHC and LUAD. This evidence concerns the gene DHX37 and neoplasm.